Literature DB >> 3798993

[Treatment of psoriasis arthropathica with bromocriptine].

G Weber, H Frey.   

Abstract

35 patients suffering from psoriatic arthritis were systemically treated with bromocriptine at increasing doses, starting at 2.5 mg up to 30 mg per day. In 77% of the patients, we observed significant remission; 34% showed total remission and 43% remission of approximately 50% of the articular symptoms. Previous long-term treatment with commonly used anti-rheumatic drugs was not effective in any of the cases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3798993

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  3 in total

Review 1.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

2.  Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro.

Authors:  K Morkawa; F Oseko; S Morikawa
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.

Authors:  K Morikawa; F Oseko; S Morikawa
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.